Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
INSP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$123.00 - $257.40
Previous CloseN/A
Volume95.34K
Average Volume (3M)488.48K
Market Cap
$4.68B
Enterprise Value$5.29B
Total Cash (Recent Filing)$150.15M
Total Debt (Recent Filing)$30.04M
Price to Earnings (P/E)90.7
Beta0.65
Next Earnings
May 06, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.73
Shares Outstanding29,759,651
10 Day Avg. Volume386,951
30 Day Avg. Volume488,482
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.09
Price to Cash Flow (P/CF)17.70
P/FCF Ratio19.70
Enterprise Value/Market Cap1.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.78
Enterprise Value/Ebitda81.31
Forecast
1Y Price Target
$232.69Price Target Upside47.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
---
Inspire Medical Systems News
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceINSP outperformed in margin and operating expense leverage, resulting in strong cash flow and a robust cash position at the end of FY24.
Future Growth ProspectsShares remain at an attractive entry point as 2025 tailwinds stack for Inspire, including Inspire V launch, payor coverage for expanded AHI/BMI coverage, and early innings of GLP-1 halo effect and replacement cycle.
ProfitabilityProfitability continues to shine, with INSP's continued outperformance below the topline.
Bears Say
Legal RisksA new Department of Justice investigation could create a potential overhang on the shares.
Market ReactionA civil investigative demand from the DOJ regarding marketing, promotional, and reimbursement practices is likely driving post-market softness.
Operational ChallengesThe Inspire V launch timing is driven by inventory build, which is taking longer than expected due to the need to scale up a new production line.
---
Ownership Overview
1.52% Insiders
46.60% Mutual Funds
0.12% Other Institutional Investors
28.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $123.00 and its highest was $257.40 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Inspire Medical Systems’s market cap is $4.68B.
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is May 06, 2025 which is in 37 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Feb 10, 2025. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.732 by $0.418.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is -0.24.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 29,759,651 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $1.15 in its last earnings report, beating expectations of $0.732. Following the earnings report the stock price went up 1.658%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Currently, no hedge funds are holding shares in INSP
---
Inspire Medical Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$232.69 (47.98% Upside)
$232.69 (47.98% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 31.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.79%
12-Months-Change
Fundamentals
Return on Equity
8.48%
Trailing 12-Months
Asset Growth
19.44%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
---
INSP Company Deck
---
INSP Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call demonstrated strong financial performance and growth, including achieving profitability and significant revenue increases, particularly internationally. However, the call also highlighted potential challenges, such as the ongoing DOJ investigation and reimbursement complexities with the transition to the Inspire V device. Despite these challenges, the overall outlook remains positive with strong guidance for 2025.Read More>---
INSP Revenue Breakdown
97.02% U.S.
2.98% Other
---
INSP Stock 12 Month Forecast
Average Price Target
$232.69
▲(47.98% Upside)
Technical Analysis
Best Analysts Covering INSP
1 Year
1 Year Success Rate
16/31 ratings generated profit
1 Year Average Return
+18.77%
reiterated a buy rating 24 days ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 51.61% of your transactions generating a profit, with an average return of +18.77% per trade.
---